IGF1 and proximal spinal muscular atrophy: In a severe mouse model of SMA, the intravenous administration of AAV vectors encoding hr-IGF-1 at postnatal day 1 reduced MN degeneration and increased innervation at the neuromuscular junction after 7 days, and it prolonged the mouse survival (Tsai et al., 2014).